Jan. 22 at 4:40 PM
$CELZ in the back trial, they started with the low dose cohorts first. Not sure why Tim omitted this information, but the fact is with the higher dose cohorts, this group will most likely see even stronger outcomes. But again, even the low dose group had great results!